ECO Animal Health Group plc (AIM:EAH)

Market Cap	64.71M +18.6%
Revenue (ttm)	87.53M +10.0%
Net Income	2.19M +29.9%
EPS	0.03 +29.6%
Shares Out	67.76M
PE Ratio	30.32
Forward PE	25.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,406
Open	95.00
Previous Close	95.50
Day's Range	94.00 - 97.00
52-Week Range	80.01 - 116.90
Beta	-0.01
Analysts	Strong Buy
Price Target	202.00 (+111.52%)
Est. Earnings	Nov 27, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 213
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In fiscal year 2026, ECO Animal Health Group's revenue was 87.53 million, an increase of 9.96% compared to the previous year's 79.60 million. Earnings were 2.19 million, an increase of 29.89%.

Analyst Summary

According to 4 analysts, the average rating for EAH stock is "Strong Buy." The 12-month stock price target is 202p, which is an increase of 111.52% from the latest price.

Price Target

202p

(111.52% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error